MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$3.68
+5.75% today
Updated 2026-04-30
Market cap
$542.79M
P/E ratio
—
P/S ratio
2.92x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$2 – $4
Volume
1.8M
Maravai Lifesciences Holdings Inc (MRVI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-186000.00 | $24.11M | $152.19M | $368.57M | $535.98M | $126.22M | $7.46M | $-57.57M |
| Capital expenditures | $3.61M | $17.15M | $25.41M | $14.85M | $17.09M | $65.55M | $29.66M | $13.15M |
| Depreciation | $22.35M | $24.08M | $25.84M | $24.75M | $38.10M | $48.78M | $56.87M | — |
| Stock-based comp | $2.12M | $1.68M | $24.63M | $10.46M | $18.67M | $34.59M | $49.41M | $30.17M |
| Free cash flow | $-3.80M | $6.97M | $126.78M | $353.72M | $518.89M | $60.67M | $-22.19M | $-70.72M |
| Investing cash flow | $-3.45M | $-17.15M | $6.07M | $105.66M | $-267.61M | $-122.31M | $-24.32M | — |
| Financing cash flow | $-9.17M | $-4.17M | $53.21M | $-159.05M | $-187.50M | $-61.09M | $-235.71M | — |
| Dividends paid | $52.06M | $97.05M | $609.32M | $153.45M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $315.18M | — | — | — | — |